Interview: Philip Nitschke on life in the Netherlands

Life on a Dutch houseboat   

Dr Philip Nitschke is probably the world’s best-known activist for assisted suicide. Yesterday he declared that the UK government should offer prisoners sentenced to life without parole the option of taking a lethal euthanasia drug like Nembutal. "To do less is cruel and inhumane," he told the media.

Although he is an Australian, he and his wife recently relocated to the Netherlands where he continues with his work. BioEdge asked him why he moved house and what it means for the organisation he founded, Exit International.  


BioEdge: Why have you moved to the Netherlands? When did you decide?

Philip Nitschke: I moved to the Netherlands with my wife because we needed to publish the Peaceful Pill eHandbook in multiple languages. Being in the midst of the European Union was essential for that. The need to leave home also became increasingly evident because of the failure in Australia to see the question of end of life choice depicted in anything other than the “medical model” ie, as a medically mediated option for the dying, rather that the “rights” model that I see as the more ethically consistent approach.

Do you still call Australia home, or are you too angry with the law and the medical establishment to return?

Nitschke: Yes, Darwin will always be my home.

Life on a houseboat in a Dutch canal sounds rather picturesque -- but a bit chillier than Darwin. Do you plan to settle down, learn the language, and so on?

Nitschke: Yes, very picturesque, and we have settled down, the dog is here, too, so it’s all the family. Office and new laboratory opens this week. We have enrolled in our first language course in January. (They don’t call it “double Dutch” for nothing!)

How are you contributing to the local euthanasia debate in the Netherlands? Your idea of rational suicide is quite similar to Dutch proposals for “completed lives”, isn’t it?

Nitschke: It is refreshing to see the “rational suicide” or “civil rights” model under active discussion and consideration in Europe. The proposed “completed life” model sits very well with my views.

How do the locals like the idea of the "peaceful pill"? Is it similar to the Drion's Pill which has provoked a lot of discussion in the Netherlands?

Nitschke: My concept of a “Peaceful Pill” flowed directly from my discussions about this with [Huib] Drion* when I met with him in the Hague some 10 years ago. The idea has broad acceptance and fits well with the Dutch idea of “completed life”. It is an area of active research by Exit, from Drion’s two-stage pill to the concept of unique individual pill coding.

I see that you are giving a talk at an NVVE** conference in December. What’s all that about?

Nitschke: I will be talking on the political and ideological schism between those who believe in the “medical model” and civil rights models of end-of-life choice and the implications of this globally. Of critical importance is access to the most current information, to good quality euthanasia drugs, and testing facilities.

And how is Exit International functioning now that you have left Australia? I see that you have offices in the Netherlands and Switzerland.

Nitschke: Exit in Australia and NZ is functioning well. We have a great staff and volunteer team, some very talented and committed people. Regular visits home allow me to be active in multiple countries. Exit is now much bigger than me personally.

* Huib Drion (1917-2004) was a Dutch jurist who became famous for proposing a freely available suicide pill for people over 70.

** The Dutch Right to Die Association

MORE ON THESE TOPICS | assisted suicide, euthanasia, interviews, netherlands, philip nitschke

This article is published by Philip Nitschke and BioEdge under a Creative Commons licence. You may republish it or translate it free of charge with attribution for non-commercial purposes following these guidelines. If you teach at a university we ask that your department make a donation. Commercial media must contact us for permission and fees. Some articles on this site are published under different terms.

 Search BioEdge

 Subscribe to BioEdge newsletter
rss Subscribe to BioEdge RSS feed

comments powered by Disqus